The weekly litigation news digest is live. Subscribe now

IP Verse

Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of Asthma - EP3034073

The patent EP3034073 was granted to Chiesi Farmaceutici on Jun 12, 2019. The application was filed on Apr 16, 2008 under application number EP16152451A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3034073

CHIESI FARMACEUTICI
Application Number
EP16152451A
Filing Date
Apr 16, 2008
Status
Opposition Rejected
Sep 8, 2023
Publication Date
Jun 12, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
LUPIN HEALTHCARE UKMar 12, 2020DEHNSWITHDRAWN
GILL JENNINGS & EVERYMar 11, 2020-ADMISSIBLE
TEVA PHARMACEUTICALSMar 4, 2020ELKINGTON AND FIFEWITHDRAWN

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO9964014
OPPOSITIONEP2146704
OPPOSITIONUS5972919
OPPOSITIONWO0189480
OPPOSITIONWO0228368
OPPOSITIONWO0228377
OPPOSITIONWO0228378
OPPOSITIONWO03074024
OPPOSITIONWO2008128685
OPPOSITIONWO9964014
SEARCHWO0228368
SEARCHWO0228377
SEARCHWO0228378
SEARCHWO2008128685
SEARCHWO9964014

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents